The mean of analysts' price targets for Cava (CAVA) points to a 33.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Amylyx Pharmaceuticals (AMLX) points to a 105.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Green Dot (GDOT) points to a 31.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 35.9% upside potential for GDS Holdings (GDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 29.1% upside potential for Ero Copper (ERO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 42.4% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 40.1% in Viant (DSP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 45.3% in Natural Gas Services (NGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

ETFs gathered $31.1 billion in capital last week, with U.S. equity ETFs leading the way with $23.3 billion in inflows.

WPM, RGLD and NGS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 20, 2025.

ATRenew Inc. (NYSE:RERE ) Q1 2025 Earnings Conference Call May 20, 2025 8:00 AM ET Company Participants Kerry Chen - Chairman, Chief Executive Officer Rex Chen - President, Chief Financial Officer Jeremy Ji - Director, Corporate Development and Investor Relations Conference Call Participants Joyce Ju - Bank of America Xiao Wan - CICC Michael Kim - Zacks Small Cap Research Operator Good morning and good evening ladies and gentlemen. Thank you for standing by, and welcome to ATRenew Inc.'s first quarter 2025 earnings conference call.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149409&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=149406&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

MasterCraft Unites Watersports Community with Season-Long Fundraising Platform to Support St. Jude's Lifesaving Mission Pledging $75,000 in 2025, Bringing Total Funds Raised to $225,000 Since 2023

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=149410&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=149407&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

WICHITA, Kan.--(BUSINESS WIRE)--Textron Aviation today celebrated the five-year anniversary of the first flight of the versatile Cessna SkyCourier, the company's clean-sheet twin-engine, high-wing utility turboprop. This is a significant milestone for this high-performing aircraft which has become a trusted asset for operators worldwide. The Cessna SkyCourier is designed and produced by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. To support growing flight activities of the SkyCour.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=149412&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=149411&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=149408&wire=1&utm_campaign=4 or contact Joseph E.